Both in Pharmaceuticals
Vistagen Therapeutics vs Actuate Therapeutics
Over the past year VTGN returned −95.5% and ACTU returned −94.2%; their daily moves had a correlation of 0.04.
VTGN −95.5% ACTU −94.2%Growth of $1, one year, split-adjusted
| Metric | VTGN | ACTU |
|---|---|---|
| Price | $0.1843 | $0.3699 |
| Market cap | $8.2M | $8.9M |
| Today | +9.70% | +5.69% |
| 1 month | −26.5% | −54.4% |
| 6 months | −69.8% | −87.6% |
| Year to date | −72.2% | −94.0% |
| 1 year | −95.7% | −94.5% |
| Revenue growth (YoY) | +504.9% | — |
| Gross margin | 100.0% | — |
| Net margin | −882.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.3× | — |
| Net cash | $31.7M | $4.4M |
| Dividend yield | — | — |
| Volatility (60d) | 107.1% | 161.7% |
| Short % of float | 5.7% | 19.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).